211 related articles for article (PubMed ID: 26830608)
1. Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients.
Kaltenbach TE; Engler P; Kratzer W; Oeztuerk S; Seufferlein T; Haenle MM; Graeter T
Abdom Radiol (NY); 2016 Jan; 41(1):25-32. PubMed ID: 26830608
[TBL] [Abstract][Full Text] [Related]
2. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
[TBL] [Abstract][Full Text] [Related]
3. [Benign focal liver lesions detected by computed tomography: Review of 1,184 examinations].
Horta G; López M; Dotte A; Cordero J; Chesta C; Castro A; Palavecino P; Poniachik J
Rev Med Chil; 2015 Feb; 143(2):197-202. PubMed ID: 25860362
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis.
Vilgrain V; Uzan F; Brancatelli G; Federle MP; Zappa M; Menu Y
Radiology; 2003 Oct; 229(1):75-9. PubMed ID: 12944594
[TBL] [Abstract][Full Text] [Related]
6. [Ultrasound-guided thin-needle biopsy in focal liver diseases. II. Benign focal liver diseases].
Wernecke K; Heckemann R; Rehwald U
Ultraschall Med; 1984 Dec; 5(6):303-11. PubMed ID: 6098012
[TBL] [Abstract][Full Text] [Related]
7. [Benign liver tumors].
Cherqui D
J Chir (Paris); 2001 Feb; 138(1):19-26. PubMed ID: 11240457
[TBL] [Abstract][Full Text] [Related]
8. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
[TBL] [Abstract][Full Text] [Related]
9. Characterizing benign liver lesions and trauma with contrast-enhanced ultrasound.
Wills M; Harvey CJ; Kuzmich S; Afaq A; Lim A; Cosgrove D
Br J Hosp Med (Lond); 2014 Feb; 75(2):91-5. PubMed ID: 24521804
[TBL] [Abstract][Full Text] [Related]
10. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
11. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.
Reddy KR; Kligerman S; Levi J; Livingstone A; Molina E; Franceschi D; Badalamenti S; Jeffers L; Tzakis A; Schiff ER
Am Surg; 2001 Feb; 67(2):173-8. PubMed ID: 11243545
[TBL] [Abstract][Full Text] [Related]
12. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
13. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
Ott R; Hohenberger W
Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
[TBL] [Abstract][Full Text] [Related]
14. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
16. Integrated imaging of hepatic tumors in childhood. Part II: Benign lesions (congenital, reparative, and inflammatory).
Miller JH; Greenspan BS
Radiology; 1985 Jan; 154(1):91-100. PubMed ID: 3880615
[TBL] [Abstract][Full Text] [Related]
17. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis.
Faccioli N; D'Onofrio M; Comai A; Cugini C
Radiol Med; 2007 Sep; 112(6):810-20. PubMed ID: 17891342
[TBL] [Abstract][Full Text] [Related]
19. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
[TBL] [Abstract][Full Text] [Related]
20. Benign focal liver lesions: discrimination from malignant mimickers.
Alobaidi M; Shirkhoda A
Curr Probl Diagn Radiol; 2004; 33(6):239-53. PubMed ID: 15549050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
